UK-India free trade agreement could spark pharma patent litigation
By Douglas Clarke-Williams ( August 5, 2026, 15:56 GMT | Comment) -- Pharmaceutical patent holders in the UK could be facing new efforts to invalidate their protections and open the door for generic medications from India, after the free trade agreement between the countries eliminated tariffs on imports of medicines.Pharmaceutical patent holders in the UK could soon face a new push to invalidate their protections, after a free trade agreement with India which came into force in July eliminated import duties on almost all Indian drugs and medical devices....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.